Cue Health Inc. announced that on October 7, 2022, Sachin H. Jain, M.D. was appointed to the Board of Directors to serve as a director with a term of office expiring at the Company's annual meeting of stockholders to be held in 2025. In connection with this appointment, the Board increased the size of the Board from six to seven members. Dr. Jain has served as President and Chief Executive Officer of SCAN Group and Health Plan, a not-for-profit Medicare Advantage plan since July 2020 and as Academic Hospitalist at the U.S. Department of Veterans Affairs since April 2021.

From 2014 to 2020, he held several increasing leadership positions at CareMore & Aspire Health, which are healthcare delivery systems, including President and Chief Executive Officer. From 2012 to 2014, Dr. Jain was Chief Medical and Information Officer at Merck & Co. (Nasdaq: MRK), a biopharmaceutical company.

From 2009 to 2011, he worked in several leadership roles at the U.S. Department of Health and Human Services, including as senior advisor to the administrator of the Centers for Medicare & Medicaid Services. Dr. Jain is an adjunct professor of medicine at the Stanford University School of Medicine and a contributor to Forbes. In addition, Dr. Jain has served as a member of the board of directors of Cardiovascular Systems Inc., since January 2021.

He also serves as a member of the Board of Directors of America's Health Insurance Plans (AHIP), Abode Hospice, the Make-A-Wish Foundation and Biofurmis Inc. He is also an Aspen Institute Health Innovator's Fellow. Dr. Jain holds a B.A. in government, an M.B. A and a M.D. from Harvard University.